Analystreport

Adaptive Biotechnologies (NASDAQ:ADPT) had its "buy" rating reaffirmed by analysts at BTIG Research. They now have a $22.00 price target on the stock, up previously from $21.00.

Adaptive Biotechnologies Corporation  (ADPT) 
Last adaptive biotechnologies corporation earnings: 2/26 04:05 pm Check Earnings Report
US:NASDAQ Investor Relations: adhc.com